Delivery Order SPE2DR25D3013-SPE2DR26F6X5F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,570.08 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,184.59 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xcopri 200 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,477.78 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packaging) on January 14, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. The delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,731.30 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by January 13, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.40 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,801.47 on December 18, 2025, for the supply of Xcopri 150 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,262.96 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on December 12, 2025, with completion targeted for December 15, 2025, represents a competitive, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.97 to AmerisourceBergen Drug Corp for Xcopri 150 mg tablets (30-count units) on August 14, 2025, with completion targeted for August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $6,848.28. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6X5FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,802.07 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in fulfilling federal medical procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency. The IDC vehicle under which this award was issued encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. This competitively awarded delivery order for Xcopri, a neurological medication, aligns with the company's established role as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/19/26 |